Cocrystal Pharma, Inc. (COCP): Net Income
-$8.83M
Year ended 2025-12-31
-$9.94M
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$8.83M | n/m | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | -$17.50M | n/m | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | -$17.98M | n/m | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | -$38.84M | n/m | 2024-03-28, From 2022-01-01 |
| 2021-12-31 | -$14.19M | n/m | 2023-03-29, From 2021-01-01 |
| 2020-12-31 | -$9.65M | n/m | 2022-03-23, From 2020-01-01 |
| 2019-12-31 | -$48.17M | n/m | 2021-03-17, From 2019-01-01 |
| 2018-12-31 | -$49.05M | n/m | 2020-03-27, From 2018-01-01 |
| 2017-12-31 | -$613.0K | n/m | 2019-04-01, From 2017-01-01 |
| 2016-12-31 | -$74.87M | n/m | 2018-03-21, From 2016-01-01 |
| 2015-12-31 | -$50.12M | n/m | 2018-03-21, From 2015-01-01 |
| 2014-12-31 | -$99.0K | n/m | 2017-03-31, From 2014-01-01 |
| 2013-12-31 | -$3.89M | n/m | 2015-03-31, From 2013-01-01 |
| 2012-12-31 | -$7.96M | n/m | 2014-03-31, From 2012-01-01 |
| 2011-12-31 | -$5.46M | n/m | 2013-04-01, From 2011-01-01 |
| 2010-12-31 | -$319.8K | n/a | 2012-04-16, From 2010-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | 2025-12-31 | -$8.83M | n/m |
| MAIA Biotechnology, Inc. (MAIA) | 2025-12-31 | -$22.40M | n/m |
| FibroBiologics, Inc. (FBLG) | 2025-12-31 | -$18.65M | n/m |
| Can-Fite BioPharma Ltd. (CANF) | 2025-12-31 | -$9.83M | n/m |
| Kala Bio, Inc. (KALA) | 2025-12-31 | -$26.98M | n/m |
| Korsana Biosciences, Inc. (KRSA) | 2025-12-31 | -$3.53M | n/m |
| Medicus Pharma Ltd. (MDCX) | 2025-12-31 | -$47.28M | n/m |
| Oragenics Inc (OGEN) | 2025-12-31 | -$9.84M | n/m |
| Indaptus Therapeutics, Inc. (INDP) | 2025-12-31 | -$20.85M | n/m |
Compare COCP, MAIA, FBLG, CANF side by side · Screen every company in Pharmaceutical Preparations ↗